Quadrant Capital Group LLC Agenus Inc Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024
SELL
$0.63 - $1.14 $68 - $123
-108 Reduced 4.44%
2,322 $1,000
Q3 2023

Nov 14, 2023
SELL
$1.12 - $1.88 $5,381 - $9,033
-4,805 Reduced 66.41%
2,430 $2,000
Q2 2023

Aug 09, 2023
SELL
$1.31 - $2.04 $4,025 - $6,268
-3,073 Reduced 29.81%
7,235 $11,000
Q1 2023

May 11, 2023
BUY
$1.45 - $2.95 $14,946 - $30,408
10,308 New
10,308 $15,000

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email